These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 18414186

  • 21. Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?
    Neeli H, Rader DJ.
    Cardiol Clin; 2008 Nov; 26(4):537-46. PubMed ID: 18929230
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.
    Yvan-Charvet L, Matsuura F, Wang N, Bamberger MJ, Nguyen T, Rinninger F, Jiang XC, Shear CL, Tall AR.
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1132-8. PubMed ID: 17322101
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. High-density lipoprotein: a fall from grace?
    van Leuven SI, Stroes ES, Kastelein JJ.
    Ann Med; 2008 May; 40(8):584-93. PubMed ID: 18608128
    [Abstract] [Full Text] [Related]

  • 26. CETP inhibition in cardiovascular risk management: a critical appraisal.
    Dullaart RP, Dallinga-Thie GM, Wolffenbuttel BH, van Tol A.
    Eur J Clin Invest; 2007 Feb; 37(2):90-8. PubMed ID: 17217373
    [Abstract] [Full Text] [Related]

  • 27. A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development.
    Zhao L, Jin W, Rader D, Packard C, Feuerstein G.
    Biochem Pharmacol; 2009 Aug 15; 78(4):315-25. PubMed ID: 19539799
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Anacetrapib: hope for CETP inhibitors?
    Gurfinkel R, Joy TR.
    Cardiovasc Ther; 2011 Oct 15; 29(5):327-39. PubMed ID: 20406242
    [Abstract] [Full Text] [Related]

  • 32. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
    Klerkx AH, El Harchaoui K, van der Steeg WA, Boekholdt SM, Stroes ES, Kastelein JJ, Kuivenhoven JA.
    Arterioscler Thromb Vasc Biol; 2006 Apr 15; 26(4):706-15. PubMed ID: 16439711
    [Abstract] [Full Text] [Related]

  • 33. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 15; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 34. Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention.
    Sirtori CR.
    Expert Opin Investig Drugs; 2011 Nov 15; 20(11):1543-54. PubMed ID: 21961529
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors.
    Clark RW.
    Curr Opin Pharmacol; 2006 Apr 15; 6(2):162-8. PubMed ID: 16487747
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.
    Shah PK.
    Eur Heart J; 2007 Jan 15; 28(1):5-12. PubMed ID: 17121756
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Is high HDL cholesterol always good?
    Olsson AG.
    Ann Med; 2009 Jan 15; 41(1):11-8. PubMed ID: 19085339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.